Home › Cardiovascular Disease › California › Lancaster
Cardiovascular Disease clinical trials in Lancaster, CA
3 studies for Cardiovascular Disease are looking for participants at sites in and around Lancaster (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Lancaster
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- First Valley Medical Group, Lancaster
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Lancaster
Cardiovascular Disease trials in other cities
- Boston, MA34 studies
- New York City, NY30 studies
- Washington, DC27 studies
- Dallas, TX24 studies
- Houston, TX22 studies
- Philadelphia, PA22 studies
- Pittsburgh, PA21 studies
- St. Louis, MO20 studies
- Cleveland, OH20 studies
- San Francisco, CA20 studies
- Chicago, IL20 studies
- Atlanta, GA20 studies
Other studies in Lancaster
- Crohn's Disease7 studies
- Steatotic Liver Disease6 studies
- Ulcerative Colitis5 studies
- Non-Small Cell Lung Cancer4 studies
- Asthma4 studies
- Type 2 Diabetes4 studies
- High Blood Pressure3 studies
- Irritable Bowel Syndrome3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.